Assessing the Value of Cancer Treatments

Steven O’Day, MD

Video Categories: Value

Dr. Steve O’Day believes a treatment’s value incorporates combination of benefits, side-effects, and cost, stating that if the cost is high, we need to make sure the benefits are huge as well.
January 16, 2019

Impact of Reimbursement for Biomarker Testing on Clinical Practice

Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”

August 15, 2013

Personalizing Therapy for Patients With CML

Dr. Mauro addresses the debate over selecting first line therapy with three approved agents available.